Human Suicide, an Overview of Management Strategies
Journal of Clinical and Medical Reviews · 2024
DOI: 10.58489/2836-2330/021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Medical Reviews, 2024. Verfasst von Da-Yong Lu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Suicide is still a biologically mystery process with a high rate of human mortality. Early clinical evidence suggests that external and internal stresses may drive human neuropsychiatric instability and suicide behavior. Influenced by different stresses, clinical suicide prevention and treatment needs ever-growing diagnostic and therapeutic transition. Bridging the gap between molecular basis and psychiatric intervene has great medical or pharmaceutical importance. Currently, neural-psychiatric evidence and association has provided profound impacts in suicide knowledge gains in experiments and clinics. A great deal of neurobiological and psychopharmacological study can bring new hope for human suicide prevention in completeness. Public health and therapeutic basis are discussed. Final medical success (molecular targeting and curative therapies) in the clinic will ensure high-quality pharmaceutical exists for great numbers of diathesis-tendency and potential suffers. Conclusion: Next generation of clinical suicide prediction, pharmacology and therapeutic landscapes will be emerged in the near future.
Zitieren
APA
Lu, D., Wu, H., & Lu, T. (2024). Human Suicide, an Overview of Management Strategies. Journal of Clinical and Medical Reviews. https://doi.org/10.58489/2836-2330/021
Vancouver
Lu D, Wu H, Lu T. Human Suicide, an Overview of Management Strategies. Journal of Clinical and Medical Reviews. 2024. doi:10.58489/2836-2330/021
BibTeX
@article{Lu2024,
author = {Lu, Da-Yong and Wu, Hong-Ying and Lu, Ting-Ren},
title = {Human Suicide, an Overview of Management Strategies},
journal = {Journal of Clinical and Medical Reviews},
year = {2024},
doi = {10.58489/2836-2330/021}
}
EUVIMED